InvestorsHub Logo
Followers 131
Posts 11471
Boards Moderated 0
Alias Born 01/06/2010

Re: Amatuer17 post# 136381

Tuesday, 01/12/2016 7:26:51 AM

Tuesday, January 12, 2016 7:26:51 AM

Post# of 403174
That would absolutely NOT be a "killing delay". It really wouldn't be much longer than others have experienced, and this is a new platform that is getting close scrutiny by the fda. Your view looks extreme to me.

That said, some of the share price projection numbers bandied about on this board are equally extreme.

The most valuable information to use as a guide is the experience of other companies. Although each situation is unique in some ways, this approach really cuts through both the hype and the bash.

My personal view is that the Trius case study is very informative. CTIX mgmt has also suggested looking at dalvance. Right now a company called motif is also readying a p3 ABSSSI study. There are others as well. When all this information is taken together, it becomes easier to see how CTIX fits in and what needs to be done. In my view, post phase 3 ABSSSI, b will be worth about $750 million once the results are in. That alone puts us at 5 bucks or so In the meantime price will be volatile

Have a great day.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News